Desktop Site
|
05 Feb 25 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
BSE SENSEX
78,271.28
-312.53
-0.40 %
Corporate Announcement
Security Code
526139
Company
TRANSGENE BIOTEK LTD.
Exchange Received Time
24/01/2025 12:45:03
Exchange Disseminated Time
24/01/2025 12:45:06
Time Taken
00:00:03
Board Meeting Outcome for Outcome Of Board Meeting - Scrip Code 526139 |
1/24/2025 12:45:06 PM
This has reference to our letter dated January 16 2025. 1) The Board has considered and approved the unaudited Consolidated & Standalone Financial Results of the company, for the Quarter ended 31.12.2024 in accordance with the Indian Accounting Standards (IND-AS) as per Companies (Indian Accounting Standards) Rules, 2015. 2) Limited Review Report on the Unaudited Standalone and Consolidated Financial Results of the Company, for the quarter ended 31.12.2024 has also been approved. 3) The Board has discussed and approved a funding proposal to raise funds on a securitized basis to address the pressing demands on the company and passed appropriate resolution to move the proposal forward. The meeting commenced at 11:00 a.m. and concluded at 12:25 p.m.
Attachment
<< Back
Recently Viewed